Zepbound (tirzepatide) is a prescription injection that comes as a single-dose pen or single-dose vial. If your doctor prescribes Zepbound to you and you need to travel, there are certain things ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...

CagriSema, which underperformed expectations in its first Phase 3 test, will be studied at different doses and for longer ...

“It never occurred to me to ask, Well, what does this mean for us?” Jeanne took her first dose of Zepbound on March 7, 2024. Since then, she has lost 60 pounds; a recent liver scan showed no ...

A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

After reaching the highest dose, she stopped losing weight as rapidly ... referring to the active ingredient in Lilly's Zepbound/Mounjaro. "We don't necessarily agree with all those viewpoints ...

but doses for every patient are individualized. For instance, the Zepbound (tirzepatide) maximum pen dose is 15 mg, the lowest 2.5 mg. Koniver said he usually starts women on 1.5 mg of tirzepatide ...

Novo Nordisk on Wednesday said its new trial of its next-generation obesity drug candidate CagriSema will look at dose ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with competitor Eli Lilly’s Zepbound.